1. Home
  2. HIHO vs KZIA Comparison

HIHO vs KZIA Comparison

Compare HIHO & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

HOLD

Current Price

$1.71

Market Cap

4.8M

Sector

Industrials

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$6.40

Market Cap

161.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIHO
KZIA
Founded
1990
1994
Country
Hong Kong
Australia
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
161.5M
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
HIHO
KZIA
Price
$1.71
$6.40
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$17.67
AVG Volume (30 Days)
8.2M
241.3K
Earning Date
12-15-2025
12-26-2025
Dividend Yield
7.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,143,000.00
$1,199,108.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$2.86
52 Week High
$2.21
$17.40

Technical Indicators

Market Signals
Indicator
HIHO
KZIA
Relative Strength Index (RSI) 70.79 36.33
Support Level $0.77 $6.65
Resistance Level $1.75 $11.06
Average True Range (ATR) 0.17 1.97
MACD 0.08 -0.71
Stochastic Oscillator 64.58 0.00

Price Performance

Historical Comparison
HIHO
KZIA

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: